| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.6B | $11.8B | $9.9B | $9.6B | $9.2B | $8.2B | $5.8B | $5.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Operating Income | $4.9B | $4.3B | $3.7B | $3.6B | $3.4B | $0.8B | $0.6B | $0.7B |
| Net Income | $3.3B | $2.8B | $2.4B | $1.4B | $4.1B | $0.5B | $0.4B | $0.6B |
| EPS (Basic) | $5.79 | $4.80 | $4.20 | $2.59 | $7.22 | $0.94 | $0.81 | $1.07 |
| EPS (Diluted) | $5.77 | $4.78 | $4.19 | $2.58 | $7.18 | $0.93 | $0.80 | $1.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $136.9B | $139.4B | $136.1B | $194.3B | $193.5B | $126.2B | $94.5B | $92.8B |
| Current Assets | $85.8B | $89.1B | $85.0B | $156.9B | $154.3B | $87.2B | $68.0B | $66.7B |
| Cash & Equivalents | $0.8B | $0.8B | $0.9B | — | — | — | — | — |
| Total Liabilities | $107.9B | $111.7B | $110.3B | $171.6B | $170.8B | $106.6B | $77.1B | $75.5B |
| Current Liabilities | $84.1B | $89.6B | $84.6B | $149.2B | $153.4B | $88.0B | $68.8B | $66.1B |
| Stockholders' Equity | $28.9B | $27.6B | $25.7B | $22.7B | $22.7B | $19.5B | $17.3B | $17.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.7B | $4.6B | $3.5B | $3.6B | $3.1B | $2.9B | $2.7B | $2.5B |
| Investing Cash Flow | $-4.2B | $-0.9B | $-8.8B | $0.7B | $-0.8B | $-9.8B | $-0.6B | $-1.8B |
| Capital Expenditures | $0.4B | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-6.3B | $0.1B | $-64.3B | $-1.8B | $62.0B | $6.7B | $-1.8B | $-0.5B |